Inovio Pharmaceuticals Inc. Stock Advances 213.7%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rocketed 213.7% to $1.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,983.98 and the NASDAQ Composite Index falling 1.1% to 25,164.32.

The stock's rise snapped a two-day losing streak.

Inovio Pharmaceuticals Inc. closed 30.5% short of its 52-week high of $2.72, which the company reached on December 17th.

The stock outperformed some of its peers, as Johnson & Johnson fell 1.0% to $270.56, Statera Biopharma Inc. rose 100.0% to $0.00, and Pfizer Inc. rose 0.49% to $30.67.

Trading volume totaled 218.5 million, compared to the 50-day average of 5.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 02, 2026 16:33 ET (21:33 GMT)